AONL
Content by and about the American Organization for Nursing Leadership (AONL).
The Food and Drug Administration (FDA) released a document this week to help accelerate the development of prevention and treatment options for COVID-19.
The Centers for Medicare and Medicaid Services (CMS) continues to release waivers to provide health care organizations with flexibility to respond to the COVID-19 public health emergency.
Remdesivir, an experimental drug found useful in shortening the duration of COVID-19, is being allocated to those regions hardest hit by the pandemic.
In response to the pandemic, opportunities to learn about timely topics are now widely available at no cost. On May 18, the Johns Hopkins School of Nursing will begin a two-week course for nurses on how to provide high quality care during a time of low resources and high uncertainty.
A recent advisory from the American Hospital Association (AHA) compiles useful information on maternal and neonatal practices during COVID-19 from government agencies, academic institutions, professional associations and health care organizations.
In an essay on the changes that may occur in health care as a result of the current pandemic, Donald Berwick, MD, president emeritus and senior fellow at the Institute for Healthcare Improvement, lists choices decision-makers face today as they shape the future of health care.
To better understand operational issues related to infection control, researchers at the University of China in Hong Kong designed and implemented a high-fidelity clinical simulation of intensive care admission and intubation of a patient with suspected or known COVID-19.